Cargando…
Maternal serum NGAL in the first trimester of pregnancy is a potential biomarker for the prediction of gestational diabetes mellitus
OBJECTIVE: Gestational diabetes mellitus (GDM) has adverse effects on the health of mothers and their offspring. Currently, no known biomarker has been proven to have sufficient validity for the prediction of GDM in the first trimester of pregnancy. The aim of this study was to investigate the poten...
Autores principales: | Lu, Ling, Li, Chanyu, Deng, Jie, Luo, Jianbo, Huang, Chaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708734/ https://www.ncbi.nlm.nih.gov/pubmed/36465627 http://dx.doi.org/10.3389/fendo.2022.977254 |
Ejemplares similares
-
Putrescine as a Novel Biomarker of Maternal Serum in First Trimester for the Prediction of Gestational Diabetes Mellitus: A Nested Case-Control Study
por: Liu, Cheng, et al.
Publicado: (2021) -
AST-to-ALT ratio in the first trimester and the risk of gestational diabetes mellitus
por: An, Rongjing, et al.
Publicado: (2022) -
Predictive value of first-trimester GPR120 levels in gestational diabetes mellitus
por: He, Qingwen, et al.
Publicado: (2023) -
First Trimester Plasma MicroRNA Levels Predict Risk of Developing Gestational Diabetes Mellitus
por: Légaré, Cécilia, et al.
Publicado: (2022) -
Serum Levels and Placental Expression of NGAL in Gestational Diabetes Mellitus
por: Yin, Xiaoqian, et al.
Publicado: (2020)